✦ LIBER ✦

PCV9 COST-EFFECTIVENESS ANALYSIS OF ALTEPLASE COMPARED WITH STREPTOKINASE AND ABSENCE OF THROMBOLYTICAL THERAPY FOR MYOCARDIAL INFARCTION

✍ Scribed by E Derkach; M Avxentieva; PA Vorobjov

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost Effectiveness of Thrombolytic Thera

✍ Mark, Daniel B.; Hlatky, Mark A.; Califf, Robert M.; Naylor, C. David; Lee, Kerr 📂 Article 📅 1995 🏛 Massachusetts Medical Society 🌐 English ⚖ 95 KB

Economics and cost-effectiveness in eval

✍ Christopher A. Lewandowski; John Kahler 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB

PCV91 COST-EFFECTIVENESS ANALYSIS OF ENO

✍ L Betegón; W Weintraub; Z Zhang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV27 COST-EFFECTIVENESS ANALYSIS OF ANT

✍ BA van Hout; MJD Tangelder; P Bervoets; S Gabriel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PCV17 Cost-Effectiveness Analysis of Bos

✍ V. Omelyanovsky; M. Avxentyeva; I. Krysanov; S. Goryaynov; O. Ivakhnenko; F.M. T 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Primary coronary angioplasty compared wi

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB